Evidence map›Paper›PMID 25262820›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2014

Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5.

M Levin, S Rotthus, S Wendel, N Najafi, E Källström, M Focke-Tejkl, R Valenta, S Flicker, M Ohlin

Open access · hybridAbstract read
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Mapping Human Monoclonal IgE Epitopes on the Major Dust Mite Allergen Der p 2.Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

M LevinDepartment of Immunotechnology, Lund University, Lund, Sweden.
S Rotthus
S Wendel
N Najafi
E Källström
M Focke-Tejkl
R Valenta
S Flicker
M Ohlin
Lund University · SEMedical University of Vienna · ATSkåne University Hospital · SE

Funding

Austrian Science Fund FWF F 4605
6 · The paper itself

Abstract

backgroundGroup 5 allergens are small proteins that consist of two domains. They belong to the most potent respiratory allergens.

objectiveTo determine the binding sites and to study allergic patients' IgE recognition of the group 5 allergen (Phl p 5) from timothy grass pollen using human monoclonal IgE antibodies that have been isolated from grass pollen allergic patients.

methodsUsing recombinant isoallergens, fragments, mutants and synthetic peptides of Phl p 5, as well as peptide-specific antibodies, the interaction of recombinant human monoclonal IgE and Phl p 5 was studied using direct binding and blocking assays. Cross-reactivity of monoclonal IgE with group 5 allergens in several grasses was studied and inhibition experiments with patients' polyclonal IgE were performed.

resultsMonoclonal human IgE showed extensive cross-reactivity with group 5 allergens in several grasses. Despite its small size of 29 kDa, four independent epitope clusters on isoallergen Phl p 5.0101, two in each domain, were recognized by human IgE. Isoallergen Phl p 5.0201 carried two of these epitopes. Inhibition studies with allergic patients' polyclonal IgE suggest the presence of additional IgE epitopes on Phl p 5. CONCLUSIONS & CLINICAL RELEVANCE: Our results reveal the presence of a large number of independent IgE epitopes on the Phl p 5 allergen explaining the high allergenic activity of this protein and its ability to induce severe allergic symptoms. High-density IgE recognition may be a general feature of many potent allergens and form a basis for the development of improved diagnostic and therapeutic procedures in allergic disease.

Indexed as

AllergensAmino Acid SequenceAntigens, PlantEpitopesGerm CellsHumansImmunoglobulin EImmunoglobulin Heavy ChainsModels, MolecularMolecular Sequence DataMutationPlant ProteinsPollenProtein BindingProtein ConformationProtein Interaction Domains and MotifsAllergensAntigens, PlantEpitopesgroup 5 allergens, AmbrosiaImmunoglobulin EImmunoglobulin Heavy ChainsPlant ProteinsRecombinant ProteinsSingle-Chain Antibodiesallergenicityconformational epitopeepitope mappinggroup 5 grass pollen allergenhuman monoclonal antibodyrecombinant allergen fragmentrecombinant antibody technology

Identifiers

PMID25262820
PMCPMC4278554
OpenAlexW2126683946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.